Advertisement

Autism

  • Mark L. Goldstein
  • Stephen Morewitz
Chapter

Abstract

Autistic spectrum disorders are lifelong severe brain-based heritable disabilities that have enormous impact on the affected individual, the individual’s family, and the community. Autistic disorder, the formal name for classical autism, falls under the category of pervasive developmental disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association and American Psychiatric Association Task Force on DSM-IV, 2000). Disorders under this category also include Asperger syndrome, pervasive developmental disorder not otherwise specified, Rett syndrome, and childhood disintegrative disorder.

Keywords

Autistic Spectrum Disorder Autistic Child Asperger Syndrome Autistic Disorder Pervasive Developmental Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abrahams, B.S., Geschwind, D.H. (2008). Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet, 9 (5), 341–355.PubMedCrossRefGoogle Scholar
  2. American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association.Google Scholar
  3. Amir, R.E., Van den Veyver, I.B., et al. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 23 (2), 185–188.PubMedCrossRefGoogle Scholar
  4. Anderson, B., Schnetz-Boutaud, N., et al. (2009). Examination of association of genes in the serotonin system to autism. Neurogenetics, 10 (3), 209–216.PubMedCrossRefGoogle Scholar
  5. Bailey, A., Le Couteur, A., et al. (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med, 25 (1), 63–77.PubMedCrossRefGoogle Scholar
  6. Baker, P., Piven, J., et al. (1998). Autism and tuberous sclerosis complex: prevalence and clinical features. J Autism Dev Disord, 28, 279–285.PubMedCrossRefGoogle Scholar
  7. Bandura, A. (1969). Principles of behavior modification. New York, NY: Holt.Google Scholar
  8. Bebko, J.M., Konstantareas, M.M., et al. (1987). Parent and professional evaluations of family stress associated with characteristics of autism. J Autism Dev Disord, 17 (4), 565–576.PubMedCrossRefGoogle Scholar
  9. Begeer, S., Bouk, S., et al. (2009). Underdiagnosis and referral bias of autism in ethnic minorities. J Autism Dev Disord, 39 (1), 142–148.PubMedCrossRefGoogle Scholar
  10. Bettelheim, B. (1967). The empty fortress: infantile autism and the birth of the self. New York, NY: The Free Press.Google Scholar
  11. Blakeslee, S. (2002). Increase in autism baffles scientists. New York, NY: The New York Times.Google Scholar
  12. Blakeslee, S. (2003). Autism diagnoses double in California. New York, NY: The New York Times.Google Scholar
  13. Bouder, J., Spielman, S., et al. (2009). Brief report: quantifying the impact of autism coverage on private insurance premiums. J Autism Dev Disord, 39 (6), 953–957.PubMedCrossRefGoogle Scholar
  14. Bransfield, R.C., Wulfman, J.S., et al. (2008). The association between tick-borne infections, lyme borreliosis and autism spectrum disorders. Med Hypotheses, 70 (5), 967–974.PubMedCrossRefGoogle Scholar
  15. Broman, S.H., Fletcher, J. (1999). The changing nervous system: neurobehavioral consequences of early brain disorders. New York, NY: Oxford University Press.Google Scholar
  16. Brookman-Frazee, L. (2004). Using parent/clinician partnerships in parent education programs for children with autism. J Posit Behav Interv, 6, 195–213.CrossRefGoogle Scholar
  17. Buck, M.L. (2000). The FDA Modernization Act of 1997: impact on pediatric medicine. Ped Pharmacotherapy, 6 (12), 1–4.Google Scholar
  18. Canitano, R. (2007). Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry, 16 (1), 61–66.PubMedCrossRefGoogle Scholar
  19. Cass, H., Gringras, P., et al. (2008). Absence of urinary opioid peptides in children with autism. Arch Dis Child, 93 (9), 745–750.PubMedCrossRefGoogle Scholar
  20. Chakrabarti, S., Fombonne, E. (2001). Pervasive developmental disorders in preschool children. J Am Med Assoc, 285 (24), 3093–3099.CrossRefGoogle Scholar
  21. Chakrabarti, S., Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry, 162 (6), 1133–1141.PubMedCrossRefGoogle Scholar
  22. Committee, I.S.R. (2004). Immunization safety review: vaccines and autism. Washington, DC: National Academy Press.Google Scholar
  23. Conciatori, M., Stodgell, C.J., et al. (2004). Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry, 55 (4), 413–419.PubMedCrossRefGoogle Scholar
  24. Coutinho, A., Sousa, I., et al. (2007). Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet, 121 (2), 243–256.PubMedCrossRefGoogle Scholar
  25. Croen, L.A., Grether, J.K., et al. (2002). The changing prevalence of autism in California. J Autism Dev Disord, 32, 207.PubMedCrossRefGoogle Scholar
  26. Dales, L., Hammer, S.J., et al. (2001). Time trends in autism and in MMR immunization coverage in California. J Am Med Assoc, 285 (9), 1183–1185.CrossRefGoogle Scholar
  27. Daniels, J.L., Forssen, U., et al. (2008). Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics, 121 (5), e1357–1362.CrossRefGoogle Scholar
  28. Davis, N., Carter, A. (2008). Parenting stress in mothers and fathers of toddlers with autism spectrum disorders: associations with child characteristics. J Autism Dev Disord, 38 (7), 1278–1291.PubMedCrossRefGoogle Scholar
  29. Depienne, C., Moreno-De-Luca, D., et al. (2009). Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 Region in autism spectrum disorders. Biol Psychiatry, 66 (4), 349–359.PubMedCrossRefGoogle Scholar
  30. DeStefano, F., Thompson, W.W. (2004). MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines, 3 (1), 19–22.PubMedCrossRefGoogle Scholar
  31. DiCicco-Bloom, E., Lord, C., et al. (2006). The developmental neurobiology of autism spectrum disorder. J Neurosci, 26 (26), 6897–6906.PubMedCrossRefGoogle Scholar
  32. Dyches, T., Wilder, L., et al. (2004). Multicultural issues in autism. J Autism Dev Disord, 34 (2), 211–222.PubMedCrossRefGoogle Scholar
  33. Durkin M.S., Maenner M.J., Newschaffer C.J., et al. (2008, December 1). Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol, 168 (11), 1268–1276. Epub 2008 Oct 21.PubMedCrossRefGoogle Scholar
  34. Farrington, C.P., Miller, E., et al. (2001). MMR and autism: further evidence against a causal association. Vaccine, 19 (27), 3632–3635.PubMedCrossRefGoogle Scholar
  35. Fatemi, S., Folsom, T., et al. (2009). Expression of GABAB receptors is altered in brains of subjects with autism. Cerebellum, 8 (1), 64–69.PubMedCrossRefGoogle Scholar
  36. Folstein, S.E., Rosen-Sheidley, B. (2001). Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet, Nature Publishing Group (2), 943–955.Google Scholar
  37. Folstein, S., Rutter, M. (1977). Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry, 18 (4), 297–321.PubMedCrossRefGoogle Scholar
  38. Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatr Res, 65 (6), 591–598.PubMedCrossRefGoogle Scholar
  39. Fombonne, E., Zakarian, R., et al. (2006). Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics, 118 (1), e139–e150.PubMedCrossRefGoogle Scholar
  40. Gabriels, R.L., Hill, D.E. (2007). Growing up with autism: working with school-age children and adolescents. New York, NY: Guilford Press.Google Scholar
  41. GAO (2005). Report to the chairman and ranking minority member, subcommittee on human rights and wellness, committee on government reform, House of Representatives, Special education: children with autism. Washington, DC: United States Government Accountability Office.Google Scholar
  42. Gerber, J.S., Offit, P.A. (2009). Vaccines: vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis, 48 (4), 456–461.PubMedCrossRefGoogle Scholar
  43. Greenspan, S.I., Brazelton, T.B., et al. (2008). Guidelines for early identification, screening, and clinical management of children with autism spectrum disorders. Pediatrics, 121 (4), 828–830.PubMedCrossRefGoogle Scholar
  44. Greenspan, S.I., Wieder, S. (1999). A functional developmental approach to autism spectrum disorders. J Assoc Persons Severe Handicaps, 24 (3), 147–161.CrossRefGoogle Scholar
  45. Greenspan, S.I., Wieder, S. (2005). Can children with autism master the core deficits and become empathetic, creative, and reflective? A ten to fifteen year follow-up of a subgroup of children with Autism Spectrum Disorders (ASD) who received a comprehensive developmental, individual-difference, relationship-based (DIR) approach. J Dev Learn Disord, 9, 39–61.Google Scholar
  46. Grice, D.E., Buxbaum, J.D. (2006). The genetics of autism spectrum disorders. Neuromolecular Med, 8 (4), 1159–1174.CrossRefGoogle Scholar
  47. Hanson, D.R., Gottesman, I. (1976). The genetics, if any, of infantile autism and childhood schizophrenia. J Autism Child Schizophr, 6 (3), 209–234.PubMedCrossRefGoogle Scholar
  48. Hastings, R.P. (2002). Parental stress and behaviour problems of children with developmental disability. J Intellect Dev Disabl, 27 (3), 149–160.CrossRefGoogle Scholar
  49. Hastings, R., Kovshoff, H., et al. (2005). Systems analysis of stress and positive perceptions in mothers and fathers of pre-school children with autism. J Autism Dev Disord, 35 (5), 635–644.PubMedCrossRefGoogle Scholar
  50. Hatton, D.D., Sideris, J., et al. (2006). Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am J Med Genet, Part A, 140A (17), 1804–1813.CrossRefGoogle Scholar
  51. Hertz-Picciotto, I., Delwiche, L. (2009). The rise in autism and the role of age at diagnosis. Epidemiology, 20 (1), 84–90.PubMedCrossRefGoogle Scholar
  52. Higgins, D.J., Bailey, S.R., et al. (2005). Factors associated with functioning style and coping strategies of families with a child with an autism spectrum disorder. Autism, 9 (2), 125–137.PubMedCrossRefGoogle Scholar
  53. Howlin, P., Goode, S., et al. (2004). Adult outcome for children with autism. J Child Psychol Psychiatry, 45 (2), 212–229.PubMedCrossRefGoogle Scholar
  54. Huang, C.H., Santangelo, S.L. (2008). Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am J Med Genet B Neuropsychiatr Genet, 147B (6), 903–913.PubMedCrossRefGoogle Scholar
  55. Hughes, J.R. (2008). A review of recent reports on autism: 1000 studies published in 2007. Epilepsy Behav, 13 (3), 425–437.PubMedCrossRefGoogle Scholar
  56. Jacobson, J.W., Mulick, J.A., et al. (1998). Cost-benefit estimates for early intensive behavioral intervention for young children with autism-general model and single state case. Behav Interv, 13 (4), 201–226.CrossRefGoogle Scholar
  57. Jamain, S., Quach, H., et al. (2002). Y chromosome haplogroups in autistic subjects. Mol Psychiatry, 7 (2), 217–219.PubMedCrossRefGoogle Scholar
  58. Jesner, O.S., Aref-Adib, M., Coren, E. (2007). Risperidone for autism spectrum disorder. Cochrane Database Syst Rev, Issue 1, Art. No.: CD005040. DOI: 10.1002/14651858.CD005040.pub2Google Scholar
  59. Kanner, L. (1943). Autistic disturbances of affective contact. Nervous Child, 2, 217–250.Google Scholar
  60. Kaye, J.A., Melero-Montes, M., et al. (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ, 322 (7284), 460–463.PubMedCrossRefGoogle Scholar
  61. Kogan, M.D., Strickland, B.B., et al. (2008). A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005–2006. Pediatrics, 122 (6), e1149–1158.CrossRefGoogle Scholar
  62. Krug, D.A., Arick, J., et al. (1980). Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry, 21 (3), 221–229.PubMedCrossRefGoogle Scholar
  63. Lai, C.S., Fisher, S.E., et al. (2001). A forkhead-domain gene is mutated in a severe speech and language disorder. Nature, 413 (6855), 519–523.PubMedCrossRefGoogle Scholar
  64. Larsson, H.J., Eaton, W.W., et al. (2005). Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol, 161 (10), 916–925.PubMedCrossRefGoogle Scholar
  65. Lee, L., Harrington, C.R., et al. (2008). Children with autism: quality of life and parental concerns. J Autism Dev Disord, 38 (6), 1147–1160.PubMedCrossRefGoogle Scholar
  66. Levy, S.E., Hyman, S.L. (2008). Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatric Clinics North Am, 17 (4), 803–820.CrossRefGoogle Scholar
  67. Leyfer, O., Folstein, S., et al. (2006). Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord, 36 (7), 849–861.PubMedCrossRefGoogle Scholar
  68. Lord, C., Risi, S., et al. (2000). The Autism diagnostic observation schedule – generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord, 30 (3), 205–223.PubMedCrossRefGoogle Scholar
  69. Lord, C., Risi, S., et al. (2006). Autism from 2 to 9 years of age. Arch Gen Psychiatry, 63 (6), 694–701.PubMedCrossRefGoogle Scholar
  70. Lord, C., Rutter, M., et al. (1994). Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord, 24 (5), 659–685.PubMedCrossRefGoogle Scholar
  71. Lovaas, O.I., Smith, T. (1989). A comprehensive behavioral theory of autistic children: paradigm for research and treatment. J Behav Ther Exp Psychiatry, 20 (1), 17–29.PubMedCrossRefGoogle Scholar
  72. Luiselli, J.K. (2008). Effective practices for children with autism: educational and behavioral support interventions that work. New York, NY: Oxford University Press.Google Scholar
  73. MacDermot, K.D., Bonora, E., et al. (2005). Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genetics, 76 (6), 1074–1080.CrossRefGoogle Scholar
  74. Madsen, K.M., Hviid, A., et al. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med, 347 (19), 1477–1482.PubMedCrossRefGoogle Scholar
  75. MMWR (1999). Notice to readers: thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR, 48 (26), 563–565.Google Scholar
  76. McDermott, S., Zhou, L., et al. (2008). Injury treatment among children with autism or pervasive developmental disorder. J Autism Dev Disord, 38 (4), 626–633.PubMedCrossRefGoogle Scholar
  77. McNamara, I.M., Borella, A.W., et al. (2008). Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral, and peptide changes. Brain Res, 1189, 203–214.PubMedCrossRefGoogle Scholar
  78. Mesibov, G.B., Shea, V., et al. (2005). The TEACCH approach to autism spectrum disorders. New York, NY: Kluwer.Google Scholar
  79. Miles, J.H., Hillman, R.E. (2000). Value of a clinical morphology examination in autism. Am J Med Genetics, 91 (4), 245–253.CrossRefGoogle Scholar
  80. Millward, C., Ferriter, M., Calver, S., et al. (2008, April 16). Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev, Issue 2, Art. No.: CD003498.Google Scholar
  81. Ming, X., Brimacombe, M., et al. (2008). Autism spectrum disorders: concurrent clinical disorders. J Child Neurol, 23 (1), 6–13.CrossRefGoogle Scholar
  82. Money, J., Bobrow, N.A., et al. (1971). Autism and autoimmune disease: a family study. J Autism Dev Disord, 1 (2), 146–160.CrossRefGoogle Scholar
  83. Muhle, R., Trentacoste, S.V., et al. (2004). The genetics of autism. Pediatrics, 113 (5), e472–486.CrossRefGoogle Scholar
  84. Myles, B.S. (2007). Autism spectrum disorders: a handbook for parents and professionals. Westport, CT: Praeger.Google Scholar
  85. National Research Council (U.S.). Committee on Educational Interventions for Children with Autism. (2001). Educating children with autism. Washington, DC: National Academy Press.Google Scholar
  86. Nicolson, G.L., Gan, R., et al. (2007). Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders. J Neurosci Res, 85 (5), 1143–1148.PubMedCrossRefGoogle Scholar
  87. Oberman, L.M., Ramachandran, V.S. (2007). The simulating social mind: the role of the mirror neuron system and simulation in the social and communicative deficits of autism spectrum disorders. Psychol Bull, 133 (2), 310–327.PubMedCrossRefGoogle Scholar
  88. Offit, P.A. (2008). Vaccines and autism revisited –The Hannah Poling case. N Engl J Med, 358 (20), 2089–2091.PubMedCrossRefGoogle Scholar
  89. Oosterling, I.J., Swinkels, S.H., et al. (2009). Comparative analysis of three screening instruments for autism spectrum disorder in toddlers at high risk. J Autism Dev Disord, 39 (6), 897–909.PubMedCrossRefGoogle Scholar
  90. Orsmond, G.I., Seltzer, M.M. (2007). Siblings of individuals with autism or Down syndrome. Effects on adult lives. J Intellect Disabil Res, 51 (Pt 9), 682–696.PubMedCrossRefGoogle Scholar
  91. Ospina, M.B., Krebs Seida, J., et al. (2008). Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One, 3 (11), e3755.PubMedCrossRefGoogle Scholar
  92. Oswald, D.P., Sonenklar, N.A. (2007). Medication use among children with autism spectrum disorders. J Child Adolesc Psychopharm, 17 (3), 348–355.CrossRefGoogle Scholar
  93. Ozonoff, S., Cathcart, K. (1998). Effectiveness of a home program intervention for young children with autism. J Autism Dev Disord, 28 (1), 25–32.PubMedCrossRefGoogle Scholar
  94. Ozonoff, S., Rogers, S.J., et al. (2003). Autism spectrum disorders: a research review for practitioners. Washington, DC: American Psychiatric Pub.Google Scholar
  95. Panerai, S., Zingale, M., et al. (2009). Special education versus inclusive education: the role of the TEACCH Program. J Autism Dev Disord, 39 (6), 874–882.PubMedCrossRefGoogle Scholar
  96. Parner, E.T., Schendel, D.E., et al. (2008). Autism prevalence trends over time in Denmark: changes in prevalence and age at diagnosis. Arch Pediatr Adolesc Med, 162 (12), 1150–1156.PubMedCrossRefGoogle Scholar
  97. Parracho, H.M., Bingham, M.O., et al. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol, 54 (10), 987–991.PubMedCrossRefGoogle Scholar
  98. Percy, A.K., Lane, J.B. (2004). Rett syndrome: clinical and molecular update. Curr Opin Pediatrics, 16 (6), 670–677.CrossRefGoogle Scholar
  99. Peters, S., Beaudet, A., et al. (2004). Autism in Angelman syndrome: implications for autism research. Clin Genet, 66 (6), 530–536.PubMedCrossRefGoogle Scholar
  100. Philippe, A., Martinez, M., et al. (1999). Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet, 8 (5), 805–812.CrossRefGoogle Scholar
  101. Probst, P., Leppert, T. (2008). Brief report: outcomes of a teacher training program for autism spectrum disorders. J Autism Dev Disord, 38 (9), 1791–1796.PubMedCrossRefGoogle Scholar
  102. Redcay, E., Courchesne, E. (2005). When is the brain enlarged in autism? A meta- analysis of all brain size reports. Biol Psychiatry, 58 (1), 1–9.PubMedCrossRefGoogle Scholar
  103. Rimland, B. (1964). Infantile autism: the syndrome and its implications for a neural theory of behavior. New York, NY: Appleton-Century-Crofts.Google Scholar
  104. Robins, D.L., Fein, D., et al. (2001). The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord, 31, 131.PubMedCrossRefGoogle Scholar
  105. Rogers, S.J., Herbison, J.M., et al. (1986). An approach for enhancing the symbolic, communicative, and interpersonal functioning of young children with autism or severe emotional handicaps. J Early Interv, 10 (2), 135–148.CrossRefGoogle Scholar
  106. Rogers, S.J., Vismara, L.A. (2008). Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol, 37 (1), 8–38.PubMedCrossRefGoogle Scholar
  107. Rutter, M. (1978). Diagnosis and definitions of childhood autism. J Autism Child Schizophr, 8 (2), 139–161.PubMedCrossRefGoogle Scholar
  108. Rutter, M. (2000). Genetic studies of autism: from the 1970s into the millennium. J Abnorm Child Psychol, 28 (1), 3–14.PubMedCrossRefGoogle Scholar
  109. Schain, R.J., Freedman, D.X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatrics, 58 (3), 315–320.CrossRefGoogle Scholar
  110. Schellenberg, G.D., Dawson, G., et al. (2006). Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry, 11 (11), 1049–1060.PubMedCrossRefGoogle Scholar
  111. Schopler, E. (1998). Behavior and cognitive therapy today: essays in honor of Hans J. Eysenck: Selected proceedings of the XXVII Congress of the European Association for Behavioral and Cognitive Therapies, Venice 1997. Kidlington, Oxford, Pergamon: xv, 339.Google Scholar
  112. Seim, A.R., Reichelt, K.L. (1995). An enzyme/brain-barrier theory of psychiatric pathogenesis: unifying observations on phenylketonuria, autism, schizophrenia and postpartum psychosis. Med Hypotheses, 45 (5), 498–502.PubMedCrossRefGoogle Scholar
  113. Sharpe, D., Rossiter, L. (2002). Siblings of children with a chronic illness: a meta- analysis. J Pediatr Psychol, 27 (8), 699–710.PubMedCrossRefGoogle Scholar
  114. Siegel, B. (2004). The pervasive developmental disorders screening test II (PDDST-II). San Antonio, TX: Harcourt Assessment.Google Scholar
  115. Silverman, C., Brosco, J.P. (2007). Understanding autism: parents and pediatricians in historical perspective. Arch Pediatr Adolesc Med, 161 (4), 392–398.PubMedCrossRefGoogle Scholar
  116. Simpson, L., Owens, P.L., Zodet, M.W., et al. (2005). Health care for children and youth in the United States: annual report on patterns of coverage, utilization, quality, and expenditures. Ambul Pediatr, 5 (1), 6–44.PubMedCrossRefGoogle Scholar
  117. Skaar, D.A., Shao, Y., et al. (2004). Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry, 10 (6), 563–571.CrossRefGoogle Scholar
  118. Skinner, B.F. (1938). The behavior of organisms. New York, NY: Appleton-Century-Crofts.Google Scholar
  119. Smith, M., Spence, M.A., et al. (2009). Nuclear and mitochondrial genome defects in autisms. Ann N Y Acad Sci, 1151 (The Year in Human and Medical Genetics 2009), 102–132.PubMedCrossRefGoogle Scholar
  120. Solomon, R., Necheles, J., et al. (2007). Pilot study of a parent training program for young children with autism: the PLAY Project Home Consultation program. Autism, 11 (3), 205–224.PubMedCrossRefGoogle Scholar
  121. Stefanatos, G. (2008). Regression in autistic spectrum disorders. Neuropsychol Rev, 18 (4), 305–319.PubMedCrossRefGoogle Scholar
  122. Steffenburg, S., Gillberg, C., et al. (1989). A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry, 30 (3), 405–416.PubMedCrossRefGoogle Scholar
  123. Steffenburg, S., Gillberg, C.L., et al. (1996). Autism in Angelman syndrome: a population-based study. Pediatr Neurol, 14 (2), 131–136.PubMedCrossRefGoogle Scholar
  124. Stoelb, M., Yarnal, R., et al. (2004). Predicting responsiveness to treatment of children with autism: a retrospective study of the importance of physical dysmorphology. Focus on Autism Other Dev Disabl, 19 (2), 66–77.CrossRefGoogle Scholar
  125. Stone, W.L., Coonrod, E.E., et al. (2004). Psychometric properties of the STAT for early autism screening. J Autism Dev Disord, 34 (6), 691–701.PubMedCrossRefGoogle Scholar
  126. Stoneman, Z. (2001, May). Supporting positive sibling relationships during childhood. Mental Retardation Dev Disabil Res, 7 (2), 134–142.CrossRefGoogle Scholar
  127. Strain, P.S., Hoyson, M. (2000). The need for longitudinal, intensive social skill intervention: LEAP follow-up outcomes for children with autism. Topics Early Child Spec Educ, 20 (2), 116–122.CrossRefGoogle Scholar
  128. Swinkels, S.H.N., Dietz, C., van Daalen, E., et al. (2006). Screening for autistic spectrum in children aged 14 to 15 months. I: the development of the Early Screening of Autistic Traits Questionnaire (ESAT). J Autism Dev Disord, 36, 723–732.PubMedCrossRefGoogle Scholar
  129. Toriello, H.V. (2008). Role of the dysmorphologic evaluation in the child with developmental delay. Pediatr Clin of North Am, 55 (5), 1085–1098.CrossRefGoogle Scholar
  130. Tsatsanis, K.D. (2003). Outcome research in Asperger syndrome and autism. Child Adolesc Psychiatric Clin North Am, 12 (1), 47–63.CrossRefGoogle Scholar
  131. Vernes, S.C., Newbury, D.F., et al. (2008). A functional genetic link between distinct developmental language disorders. N Engl J Med, 359 (22), 2337–2345.PubMedCrossRefGoogle Scholar
  132. Wakefield, A.J., Murch, S.H., et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351 (9103), 637–641.PubMedCrossRefGoogle Scholar
  133. Ward, M.J., Meyer, R.N. (1999). Self-determination for people with developmental disabilities and autism: two self-advocates’ perspectives. Focus Autism Other Dev Disabl, 14 (3), 133–139.CrossRefGoogle Scholar
  134. Wassink, T.H., Piven, J., et al. (2001). Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genetics, 105 (5), 406–413.CrossRefGoogle Scholar
  135. Weiss, R.S. (1981). INREAL intervention for language handicapped and bilingual children. J Early Interv, 4 (1), 40–51.CrossRefGoogle Scholar
  136. Whiteley, P., Rodgers, J., et al. (1999). A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism, 3 (1), 45–65.CrossRefGoogle Scholar
  137. Williams, J., Whiten, A., et al. (2004). A systematic review of action imitation in autistic spectrum disorder. J Autism Dev Disord, 34 (3), 285–299.PubMedCrossRefGoogle Scholar
  138. Wills, S., Cabanlit, M., et al. (2007). Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci, 1107 (Autoimmunity, Part C The Mosaic of Autoimmunity), 79–91.PubMedCrossRefGoogle Scholar
  139. Xiaohong Gong, E.B., Blasi, F., Claudio Toma, C.B., et al. (2008). Analysis of X chromosome inactivation in autism spectrum disorders. Am J Med Genetics, Part B: Neuropsychiatr Genet, 147B (6), 830–835.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.ChicagoUSA
  2. 2.San FranciscoUSA

Personalised recommendations